Evidence map›Paper›PMID 23968600›Full record

ArticleHealthcare policy = Politiques de sante2012

Canadian pharmacare: looking back, looking forward.

Steven G Morgan, Jamie R Daw

Abstract readHistorical Article
In one paragraph

Article in Healthcare policy = Politiques de sante, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pharmaceutical policies: effects of regulating drug insurance schemes.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Article
  3. After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.International journal of health services : planning, administration, evaluation · 2022
    Article
  4. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.International journal of health policy and management · 2020
    Article
  5. Should national pharmacare apply a value-based insurance design?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  6. Community members co-designing a trial of medication access.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  7. Evaluating the effects of Quebec's private-public drug insurance system.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Review
  8. Introduction to the Special Issue: Precarious Solidarity-Preferential Access in Canadian Health Care.Health care analysis : HCA : journal of health philosophy and policy · 2017
    Article
  9. Medication access via hospital admission.Canadian family physician Medecin de famille canadien · 2017
    Article
  10. National pharmacare: Time to move forward.Canadian family physician Medecin de famille canadien · 2016
    Article
  11. [Assurance-médicaments nationale: Le moment d'aller de l'avant].Canadian family physician Medecin de famille canadien · 2016
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Steven G MorganAssociate Professor and Associate Director, Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC.
Jamie R Daw

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite Canadians' pride in medicare and the values underpinning it, the system is conspicuously incomplete. Universal public health insurance in Canada ends as soon as a patient is handed a prescription to fill; yet prescription drugs are the second largest component of health system costs. We look back at key moments in Canadian healthcare history that shaped our pharmacare system - or lack thereof. We look forward to changes in demography and technology that will increase the need for pharmacare reform in the near future. We conclude that meaningful public engagement in pharmacare design may generate the clarity of goals and level of political support needed should windows of policy opportunity open again.

Indexed as

Insurance, Pharmaceutical ServicesNational Health ProgramsCanadaForecastingHealth ExpendituresHistory, 20th CenturyHistory, 21st CenturyHumansPrescription DrugsPrescription Drugs

Identifiers

PMID23968600
PMCPMC3430151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.